Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site pain, Vaccination site pruritus, Vaccination site vesicles
Clinical narrative: Itchy Sensation - Near Injection Site; Sore to Touch - Near Injection Site; Welts - Near Injection Site; Blisters - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical medical History Information was reported.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site). At the time of the report, VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Feb-2021 and was forwarded to the company on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical medical History Information was reported.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site). At the time of the report, VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Sore to Touch - Near Injection Site), URTICARIA (Welts - Near Injection Site) and VACCINATION SITE VESICLES (Blisters - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.